Log in

NASDAQ:FSZFirst Trust Switzerland AlphaDEX Fund Stock Price, Forecast & News

$51.17
+0.26 (+0.51 %)
(As of 08/5/2020 04:00 PM ET)
Add
Today's Range
$51.17
Now: $51.17
$51.17
50-Day Range
$47.92
MA: $49.82
$51.53
52-Week Range
$36.05
Now: $51.17
$55.46
Volume200 shs
Average Volume9,723 shs
Market Capitalization$71.64 million
P/E RatioN/A
Dividend Yield1.67%
BetaN/A

Geographic Exposure of FSZ

Sector Exposure of FSZ

Industry Exposure of FSZ


Basic Details

Issuer First Trust
Fund NameFirst Trust Switzerland AlphaDEX Fund
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:FSZ
Inception Date2/14/2012
Fund ManagerDaniel J. Lindquist, Jon C. Erickson, David G. McGarel, Roger F. Testin, Stan Ueland, Chris A. Peterson
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNASDAQ AlphaDEX Switzerland Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionEurope

Fund Statistics

Assets Under Management$165.18 million
Average Daily Volume$3,810.90
Discount/Premium0.45%

ETF Expenses

Management Fee0.80%
Other Expenses0.00%
Total Expenses0.80%
Fee Waiver0.00%
Net Expenses0.80%

Administrator, Advisor and Custodian

AdministratorBrown Brothers Harriman & Co.
AdvisorFirst Trust Advisors L.P.
CustodianBrown Brothers Harriman & Co.
DistributorFirst Trust Portfolios L.P.
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market MakerCredit Suisse
$51.17
+0.26 (+0.51 %)
(As of 08/5/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FSZ News and Ratings via Email

Sign-up to receive the latest news and ratings for FSZ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











First Trust Switzerland AlphaDEX Fund (NASDAQ:FSZ) Frequently Asked Questions

How has First Trust Switzerland AlphaDEX Fund's stock been impacted by COVID-19 (Coronavirus)?

First Trust Switzerland AlphaDEX Fund's stock was trading at $45.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, FSZ shares have increased by 12.9% and is now trading at $51.17.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of First Trust Switzerland AlphaDEX Fund?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for First Trust Switzerland AlphaDEX Fund in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for First Trust Switzerland AlphaDEX Fund
.

How were First Trust Switzerland AlphaDEX Fund's earnings last quarter?

First Trust Switzerland AlphaDEX Fund (NASDAQ:FSZ) released its quarterly earnings data on Thursday, March, 19th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.27 by $0.07.
View First Trust Switzerland AlphaDEX Fund's earnings history
.

How often does First Trust Switzerland AlphaDEX Fund pay dividends? What is the dividend yield for First Trust Switzerland AlphaDEX Fund?

First Trust Switzerland AlphaDEX Fund announced a quarterly dividend on Wednesday, June 24th. Shareholders of record on Friday, June 26th will be paid a dividend of $0.768 per share on Tuesday, June 30th. This represents a $3.07 dividend on an annualized basis and a dividend yield of 6.00%. The ex-dividend date is Thursday, June 25th.
View First Trust Switzerland AlphaDEX Fund's dividend history
.

What price target have analysts set for FSZ?

3 Wall Street analysts have issued 12 month price targets for First Trust Switzerland AlphaDEX Fund's shares. Their forecasts range from $10.00 to $14.00. On average, they expect First Trust Switzerland AlphaDEX Fund's share price to reach $12.33 in the next twelve months. This suggests that the stock has a possible downside of 75.9%.
View analysts' price targets for First Trust Switzerland AlphaDEX Fund
.

Has First Trust Switzerland AlphaDEX Fund been receiving favorable news coverage?

Headlines about FSZ stock have been trending neutral this week, InfoTrie reports. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. First Trust Switzerland AlphaDEX Fund earned a coverage optimism score of 0.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about First Trust Switzerland AlphaDEX Fund
.

What is First Trust Switzerland AlphaDEX Fund's stock symbol?

First Trust Switzerland AlphaDEX Fund trades on the NASDAQ under the ticker symbol "FSZ."

Who are First Trust Switzerland AlphaDEX Fund's major shareholders?

First Trust Switzerland AlphaDEX Fund's stock is owned by a variety of retail and institutional investors. Top institutional investors include First Trust Advisors LP (65.97%).

Which institutional investors are selling First Trust Switzerland AlphaDEX Fund stock?

FSZ stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP.

How do I buy shares of First Trust Switzerland AlphaDEX Fund?

Shares of FSZ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is First Trust Switzerland AlphaDEX Fund's stock price today?

One share of FSZ stock can currently be purchased for approximately $51.17.

How big of a company is First Trust Switzerland AlphaDEX Fund?

First Trust Switzerland AlphaDEX Fund has a market capitalization of $71.64 million.

This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.